APR 102

Drug Profile

APR 102

Alternative Names: SP-SAP; Substance P-Saporin

Latest Information Update: 30 May 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Advanced Pain Therapeutics LLC
  • Developer Advanced Pain Remedies; University of Texas Southwestern Medical Center
  • Class Analgesics; Anti-inflammatories; Biological proteins; Biological toxins; Drug conjugates; Immunotoxins; Neuropeptides; Peptides; Proteins
  • Mechanism of Action Protein synthesis inhibitors; Ribosomal protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Pain

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Pain in USA (Intrathecal, Injection)
  • 01 Jan 2014 Phase-I clinical trials in Pain in USA (Intrathecal) (NCT02036281)
  • 10 Jan 2011 Advanced Pain Therapeutics is now called Advanced Pain Remedies
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top